The Biomedical Centre enables concentration of workforce
19. 1. 2016 | 2886 visits
The new Biomedical Centre (BMC) has been formed in the new year as a result of combining four institutions, all belonging to the Slovak Academy of Sciences (SAS), to make the biggest workplace of the SAS. Almost 400 employees and undergraduate and postgraduate students work in the BMC. It has created the conditions for the concentration of modern equipment infrastructure, implementation of joint projects and close cooperation among research teams.
The Biomedical Centre was founded as a public benefit organisation on 1 January 2016 by merging four organisations - the SAS Institute of Experimental Endocrinology, the SAS Institute of Experimental Oncology, the SAS Institute of Clinical and Translational Research and the SAS Virology Institute - into a single unit. It forms part of the University Science Park for Biomedicine which was opened in the Patrónka premises of the SAS in Bratislava in December 2015. Its total cost was 39.5 million Euros, of which more than 33.6 million Euros was drawn from EU funds. The rest of the money came from the state budget. The aim of the project is to combine research and innovations with the business sphere. The Centre is equipped with modern laboratories and facilities for technology and knowledge transfer. In addition, there are offices for research workers and a management centre. It has an area of more than eighteen thousand square meters.
On Tuesday 19 January, the presidents of the four merged institutions, all four with a background in science and research, delivered speeches on their subject field and contribution to the newly-formed Biomedical Centre. "There is a concentration of specialized, first-class teams and I hope the Centre will achieve great results within the European research area," Prof. Pavol Šajgalík, the President of the SAS, stressed at the opening ceremony. In his opinion, uniting the research workforce should demonstrate that Slovak society is able to derive benefit from science. "Having scientists in one place will mean a shorter time for research and so a patient can get their medical treatment more promptly," he explained. On top of all that, research of oncological, cardiovascular, endocrinological, metabolic and infectious diseases will be of an even higher quality. Combining institutions with similar subject fields into one institution will also cut running costs. "Merging four institutions into a single unit wasnʼt an easy process. However, the new Centre significantly improves the potential and quality of research itself as well as its competitiveness internationally. All the more that the 21st century has confirmed the way that diseases act together on the health of the population. Their more complex and effective research, while making good use of all four institutionsʼ potential, will enhance the practical use of knowledge to the benefit of patients and the whole of society," said Prof. Silvia Pastoreková, who is in charge of running the Centre.
Stano Ščepán
Photo: Vladimír Šimíček
The Biomedical Centre was founded as a public benefit organisation on 1 January 2016 by merging four organisations - the SAS Institute of Experimental Endocrinology, the SAS Institute of Experimental Oncology, the SAS Institute of Clinical and Translational Research and the SAS Virology Institute - into a single unit. It forms part of the University Science Park for Biomedicine which was opened in the Patrónka premises of the SAS in Bratislava in December 2015. Its total cost was 39.5 million Euros, of which more than 33.6 million Euros was drawn from EU funds. The rest of the money came from the state budget. The aim of the project is to combine research and innovations with the business sphere. The Centre is equipped with modern laboratories and facilities for technology and knowledge transfer. In addition, there are offices for research workers and a management centre. It has an area of more than eighteen thousand square meters.
On Tuesday 19 January, the presidents of the four merged institutions, all four with a background in science and research, delivered speeches on their subject field and contribution to the newly-formed Biomedical Centre. "There is a concentration of specialized, first-class teams and I hope the Centre will achieve great results within the European research area," Prof. Pavol Šajgalík, the President of the SAS, stressed at the opening ceremony. In his opinion, uniting the research workforce should demonstrate that Slovak society is able to derive benefit from science. "Having scientists in one place will mean a shorter time for research and so a patient can get their medical treatment more promptly," he explained. On top of all that, research of oncological, cardiovascular, endocrinological, metabolic and infectious diseases will be of an even higher quality. Combining institutions with similar subject fields into one institution will also cut running costs. "Merging four institutions into a single unit wasnʼt an easy process. However, the new Centre significantly improves the potential and quality of research itself as well as its competitiveness internationally. All the more that the 21st century has confirmed the way that diseases act together on the health of the population. Their more complex and effective research, while making good use of all four institutionsʼ potential, will enhance the practical use of knowledge to the benefit of patients and the whole of society," said Prof. Silvia Pastoreková, who is in charge of running the Centre.
Stano Ščepán
Photo: Vladimír Šimíček